Skip to content
Disclosery

EXANE DERIVATIVES: D position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on D, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 24 D shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 24 shares
    Change vs previous 13F -2,716 shares

    <0.01% of the 13F portfolio, value $1,915.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 2,740 shares
    Change vs previous 13F -1,433 shares

    0.07% of the 13F portfolio, value $232,819.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 4,173 shares
    Change vs previous 13F +648 shares

    0.08% of the 13F portfolio, value $327,841.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 3,525 shares
    Change vs previous 13F +73 shares

    0.06% of the 13F portfolio, value $257,406.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 3,452 shares
    Change vs previous 13F +608 shares

    0.06% of the 13F portfolio, value $257,180.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 2,844 shares
    Change vs previous 13F +442 shares

    0.07% of the 13F portfolio, value $216,040.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 2,402 shares
    Change vs previous 13F +661 shares

    0.05% of the 13F portfolio, value $180,638.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 1,741 shares
    Change vs previous 13F not available

    0.04% of the 13F portfolio, value $137,421.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).